A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Mushrooms Bookmark and Share

Mushrooms may need more might for the cancer fight

Can white button mushrooms stop prostate cancer recurrence? In a recent clinical trial at City of Hope, two patients experienced tremendous success with tablets made from concentrated white button mushrooms. Watch this story unfold.


Behold the formidable fungus.     

 

Not quite plant and not quite animal, it grows in out-of-the-way spots, avoiding attention. But if new studies at City of Hope bear fruit, the white button mushroom may enter the spotlight.

 

City of Hope scientists are on their way toward incorporating mushrooms in a cancer-fighting strategy.

 

Over the last decade, City of Hope researchers identified and tested cancer-inhibiting compounds in the common supermarket mushroom. Their work has moved into clinical trials at City of Hope, including one that tested whether consuming mushroom extract could stave off breast cancer recurrence in postmenopausal patients.

 

Early findings from that study showed that the doses of mushroom extract that were tested blocked activity of an enzyme important to breast cancer, but not at levels likely to deter the disease. The work encourages scientists to hone their potential strategy for prevention.

 

“Future studies should focus on more highly concentrated preparations of mushroom extract,” said Melanie Palomares, M.D., M.S., assistant professor of medical oncology and director of the High Risk Breast Program, who presented the results at the meeting.

 

In earlier work, Shiuan Chen, Ph.D., chair and professor of City of Hope’s Department of Cancer Biology, found that phytochemicals — naturally occurring plant chemicals — in mushrooms can block the activity of the enzyme called aromatase.

 

Aromatase helps the body produce the hormone estrogen, which many breast cancers need to grow. Blocking the enzyme chokes off the supply of estrogen to tumor cells, stunting their growth. Several drugs that block aromatase are already part of medicine’s arsenal against breast cancer.

 

Mushrooms’ natural aromatase-inhibiting properties might offer a dietary, non-drug intervention to help prevent recurrence of hormone-dependent breast cancers, according to the researchers.

 

The current study, which aimed to find an effective dose of mushroom extract, centered on postmenopausal breast cancer survivors who were cancer-free after they finished their treatment.

 

Women in the study took white button mushroom extract daily for 12 weeks. They were divided into groups that received either 5-, 8-, 10- or 13-gram doses. The researchers checked patients’ responses by measuring blood levels of estradiol, a close chemical relative of estrogen. Women whose estradiol level dropped by 50 percent or more were deemed to have responded to the intervention.

 

Patients tolerated the extract well, but the estradiol level failed to drop by 50 percent or more in any group. The researchers did see evidence of modest aromatase inhibition that lasted as long as six hours at the highest dose level. The result suggested that eating mushrooms can weakly inhibit aromatase in patients, but much higher amounts likely are necessary for a clinically significant result.

 

“Over the course of 12 weeks, we were able to observe phytochemical activity, but not at high enough concentrations to significantly reduce circulating estrogen levels in our patients,” Palomares said. In addition to trying higher concentrations of mushroom extract in future studies, the scientists also may change the way they measure estrogens in the body. “The local estrogen level in the breast is likely more significant clinically than what circulates in the bloodstream.”

 

Mushrooms

Mushrooms may need more might for the cancer fight

Can white button mushrooms stop prostate cancer recurrence? In a recent clinical trial at City of Hope, two patients experienced tremendous success with tablets made from concentrated white button mushrooms. Watch this story unfold.


Behold the formidable fungus.     

 

Not quite plant and not quite animal, it grows in out-of-the-way spots, avoiding attention. But if new studies at City of Hope bear fruit, the white button mushroom may enter the spotlight.

 

City of Hope scientists are on their way toward incorporating mushrooms in a cancer-fighting strategy.

 

Over the last decade, City of Hope researchers identified and tested cancer-inhibiting compounds in the common supermarket mushroom. Their work has moved into clinical trials at City of Hope, including one that tested whether consuming mushroom extract could stave off breast cancer recurrence in postmenopausal patients.

 

Early findings from that study showed that the doses of mushroom extract that were tested blocked activity of an enzyme important to breast cancer, but not at levels likely to deter the disease. The work encourages scientists to hone their potential strategy for prevention.

 

“Future studies should focus on more highly concentrated preparations of mushroom extract,” said Melanie Palomares, M.D., M.S., assistant professor of medical oncology and director of the High Risk Breast Program, who presented the results at the meeting.

 

In earlier work, Shiuan Chen, Ph.D., chair and professor of City of Hope’s Department of Cancer Biology, found that phytochemicals — naturally occurring plant chemicals — in mushrooms can block the activity of the enzyme called aromatase.

 

Aromatase helps the body produce the hormone estrogen, which many breast cancers need to grow. Blocking the enzyme chokes off the supply of estrogen to tumor cells, stunting their growth. Several drugs that block aromatase are already part of medicine’s arsenal against breast cancer.

 

Mushrooms’ natural aromatase-inhibiting properties might offer a dietary, non-drug intervention to help prevent recurrence of hormone-dependent breast cancers, according to the researchers.

 

The current study, which aimed to find an effective dose of mushroom extract, centered on postmenopausal breast cancer survivors who were cancer-free after they finished their treatment.

 

Women in the study took white button mushroom extract daily for 12 weeks. They were divided into groups that received either 5-, 8-, 10- or 13-gram doses. The researchers checked patients’ responses by measuring blood levels of estradiol, a close chemical relative of estrogen. Women whose estradiol level dropped by 50 percent or more were deemed to have responded to the intervention.

 

Patients tolerated the extract well, but the estradiol level failed to drop by 50 percent or more in any group. The researchers did see evidence of modest aromatase inhibition that lasted as long as six hours at the highest dose level. The result suggested that eating mushrooms can weakly inhibit aromatase in patients, but much higher amounts likely are necessary for a clinically significant result.

 

“Over the course of 12 weeks, we were able to observe phytochemical activity, but not at high enough concentrations to significantly reduce circulating estrogen levels in our patients,” Palomares said. In addition to trying higher concentrations of mushroom extract in future studies, the scientists also may change the way they measure estrogens in the body. “The local estrogen level in the breast is likely more significant clinically than what circulates in the bloodstream.”

 
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
 
Hours: M – F, 8 a.m. to 5 p.m. (PST)
 
Calls received after 5 p.m. will be returned the next business day.
Patient Care Overview

Info for Referring Physicians
City of hope welcomes patient referrals from physicians throughout the world. City of Hope is located near northeast Los Angeles, in Duarte, California.



NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...